Lv1
30 积分 2022-08-30 加入
Bivalent anti-CD3 Fab dimers drive T cells into a highly efficient fratricide with potential clinical application
5天前
已关闭
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy
21天前
已完结
T cell killing does not require the formation of a stable mature immunological synapse
1个月前
已完结
CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity
1个月前
已完结
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
1个月前
已完结
A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
1个月前
已完结
Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells
1个月前
已完结
Co-blocking TIGIT and PVRIG using a novel bispecific antibody enhances anti-tumor immunity
2个月前
已完结
Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy
2个月前
已完结
Targeting Solid Tumors Using CD3 Bispecific Antibodies
3个月前
已完结
皖公网安备34019202002308
